Obstetric and neonatal outcomes of assisted reproductive technology programs using donor oocytes

1. La Marca A. Ovarian antimullerian hormone system: more complex than was thought. Fertil. Steril. 2019; 112(1): 42-3. https://dx.doi.org/10.1016/j.fertnstert.2019.04.042.
2. Сыркашевва А.Г., Ильина Е.О., Долгушина Н.В. Бесплодие у женщин старшего репродуктивного возраста: причины, тактика ведения, перспективы использования преимплантационного генетического скрининга (обзор литературы). Гинекология. 2016; 18(3): 40-3. [Syrkasheva A.G., Ilina E.O, Dolgushina N.V. Infertility in women of advanced age: etiology, management, application of preimplantation genetic screening. Ginecology/Ginekologiya. 2016; 18(3): 40-3. (in Russian).]
3. Долгушина Н.В., Коротченко О.Е., Бейк Е.П., Абдурахманова Н.Ф., Ильина  Е.О., Кулакова Е.В. Клинико-экономический анализ эффективности преимплантационного генетического скрининга у пациенток позднего репродуктивного возраста. Акушерство и гинекология. 2017; 11: 56-61. [Dolgushina N.V., Korotchenko O.E., Beik E.P.,Abdurakhmanova N.F., Ilyina E.O., Kulakova E.V. Clinical and cost-effectiveness analysis of preimplantation genetic screening in patients of late reproductive age. Obstetrics and Gynecology/Akusherstvo i ginekologiya. 2017; (11): 56-61. (in Russian).] https://dx.doi.org/10.18565/aig.2017.11.56-61.
4. ESHRE. Assisted Reproductive Technology (ART) in Europe 2016 and development of a strategy of vigilance. Preliminary results generated from European registers by ESHRE.
5. Регистр ВРТ РАРЧ. 2017: Отчет регистра за 2017г. и ВРТ в России 2017г. (Доклад президента РАРЧ на XXIX международной конференции РАРЧ «Репродуктивные технологии сегодня и завтра». г. Ростов-на-Дону.)
6. Сухих Г.Т., Силачев Д.Н., Горюнов К.В., Волочаева М.В., Шмаков Р.Г. Роль дисфункции стволовых клеток в развитии больших акушерских синдромов. Акушерство и гинекология. 2018; 7: 5-11. [Sukhikh G.T., Silachev D.N., Goryunov K.V., Volochaeva M.V., Shmakov R.G. Role of stem cell dysfunction in the development of great obstetrical syndromes. Obstetrics and Gynecology/Akusherstvo i ginekologiya. 2018; (7): 5-11. (in Russian).] https://dx.doi.org/10.18565/aig.2018.7.5-11.
7. Кан Н.Е., Беднягин Л.А., Долгушина Н.В., Тютюнник В.Л., Ховхаева П.А., Сергунина О.А., Тютюнник Н.В., Амирасланов Э.Ю. Клинико-анамнестические факторы риска развития преэклампсии у беременных. Акушерство и гинекология. 2016; 6: 39-44. [Kan N.E., Bednyagin L.A., Dolgushina N.V., Tyutyunnik V.L., Khovkhaeva P.A., Sergunina O.A., Tyutyunnik N.V., Amiraslanov E.Yu. Clinical and anamnestic risk factors for preeclampsia in pregnant women. Obstetrics and Gynecology/Akusherstvo i ginekologiya. 2016;(6):39–44. (in Russian).] https://dx.doi.org/10.18565/aig.2016.6.39-44.
8. Yadav V., Bakolia P., Malhotra N., Mahey R., Singh N., Kriplani A. Comparison of obstetric outcomes of pregnancies after donor-oocyte in vitro fertilization and self-oocyte in vitro fertilization: A retrospective cohort study. J. Hum. Reprod. Sci. 2018; 11(4): 370–75. https://dx.doi.org/10.4103/jhrs.JHRS_115_17.
9. Levron Y., Dviri M., Segol I., Yerushalmi G.M., Hourvitz A., R. Orvieto R. et al. The ‘immunologic theory’ of preeclampsia revisited: a lesson from donor oocyte gestations. Am. J. Obstet. Gynecol. 2014; 211(4): 383. e1-5. https://dx.doi.org/10.1016/j.ajog.2014.03.044.
10. Abdalla H.I., Billett A., Kan A.K., Baig S., Wren M., Korea L., Studd J.W. Obstetric outcome in 232 ovum donation pregnancies. 1998; 105(5): 332-7. https://dx.doi.org/10.1111/j.1471-0528.1998.tb10096.x.
11. Malchau S.S., Loft A., Larsen E.C., Aaris Henningsen A.K., Rasmussen S., Andersen A.N., Pinborg A. Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study. Fertil. Steril. 2013; 99(6): 1637-43. https://dx.doi.org/10.1016/j.fertnstert.2013.01.128.
12. Elenis E., Svanberg A.S., Lampic C., Skalkidou A., Akerud H., Sydsjo G. Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden. BMC Pregnancy Childbirth. 215; 15: 247. https://dx.doi.org/10.1186/s12884-015-0687-9.
13. Stoop D., Baumgarten M., Haentjens P., Polyzos N.P., De Vos M., Verheyen G. et al. Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod. Biol. Endocrinol. 2012; 10: 42. https://dx.doi.org/10.1186/1477-7827-10-42.
14. Gundogan F., Bianchi D.W., Scherjon S.A., Roberts D.J. Placental pathology in egg donor pregnancies. Fertil. Steril. 2010; 93(2): 397-404. https://dx.doi.org/10.1016/j.fertnstert.2008.12.144.
15. Lashley L.E., Buurma A., Swings G.M., Eikmans M., Anholts J.D., Bakker J.A., Claas F.H. Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology? J. Reprod. Immunol. 2015; 109: 17-23. https://dx.doi.org/10.1016/j.jri.2015.03.004.
16. Boulet S.L., Kawwass J.F., Crawford S., Davies M.J., Kissin D.M. Preterm birth and small size for gestational age in singleton, in vitro fertilization births using donor oocytes. Am. J. Epidemiol. 2018; 187(8): 1642-50. https://dx.doi.org/10.1093/aje/kwy051.
17. Dude A.M., Yeh J.S., Muasher S.J. Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies. Fertil. Steril. 2016; 106(3): 660-5.
18. Rodriguez-Wallberg K.A., Berger A.S., Fagerberg A., Olofsson J.I., Scherman-Pukk C., Lindqvist P.G., Nasiell J. Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study. Gynecol. Endocrinol. 2019; 35(4): 314-9. https://dx.doi.org/10.1080/09513590.2018.1528577.
19. Gibbons W.E., Cedars M., Ness R.B. Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis. Fertil. Steril. 2011; 95(5): 1645-9. e1. https://dx.doi.org/10.1016/j.fertnstert.2010.11.029.
20. Baker V.L., Brown M.B., Luke B., Conrad K.P. Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization. Fertil. Steril. 2015; 103(4): 931-8. e2. https://dx.doi.org/10.1016/j.fertnstert.2014.12.120.
21. Klatsky P.C., Delaney S.S., Caughey A.B., Tran N.D., Schattman G.L., Rosenwaks Z. The role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnancies. Obstet. Gynecol. 2010; 116(6): 1387-92. https://dx.doi.org/10.1097/AOG.0b013e3181fb8e59.
22. Zegers-Hochschild F., Masoli D., Schwarze J.E., Iaconelli A., Borges E., Pacheco I.M. Reproductive performance in oocyte donors and their recipients: comparative analysis from implantation to birth and lactation. Fertil. Steril. 2010; 93(7): 2210-5. https://dx.doi.org/10.1016/j.fertnstert.2009.01.068.

Received 19.11.2019

Accepted 29.11.2019